Muller Frank L. purchased $10K of BCAL (indirect holdings)

Muller Frank L. purchased 450 indirectly-held shares of California BanCorp \ CA (BCAL) at $22.13 on 2026-09-04.

Original reporting
SEC EDGAR · Muller Frank L.
Published Sep 10, 2026, 12:07 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 10, 2026, 12:35 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$BCAL
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

Low
01

Why it matters

Limited impact due to small transaction size; unlikely to move the stock.

02

Market read

Minor insider purchase with negligible market effect.

03

What to watch

Potential future insider activity or upcoming corporate events not disclosed.

Relevance 3/10Novelty 4/10Timing: post-market filing

Background

SEC Form 4 filing shows Director Frank L. Muller purchased 450 shares of California BanCorp at $22.13 each, totaling $9,958.50.

Market effects

none

none

none

Counterpoint

The small insider purchase may signal confidence but size is too trivial to affect price.

Key entities

  • California BanCorp

    Issuer of the shares purchased.

  • Frank L. Muller

    Director of California BanCorp.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$BCALHigh

CALIFORNIA BANCORP REPORTS THIRD QUARTER EARNINGS

California BanCorp \ CA (BCAL) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 CALIFORNIA BANCORP REPORTS THIRD QUARTER EARNINGS, HIGHLIGHTED BY STEADY LOAN GROWTH AND STRONG DEPOSIT GROWTH San Diego, Calif., October 28, 2026 – California BanCorp (“us,” “we,” “our,” or the “Company”) (NASDAQ: BCAL), the holding company for California Bank of Co

$BCALMed

CALIFORNIA BANCORP REPORTS STRONG SECOND QUARTER EARNINGS, SIGNIFICANT LOAN GROWTH AND IMPROVED CREDIT QUALITY

California BanCorp \ CA (BCAL) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 CALIFORNIA BANCORP REPORTS STRONG SECOND QUARTER EARNINGS, SIGNIFICANT LOAN GROWTH AND IMPROVED CREDIT QUALITY — Company to increase its quarterly dividend by $0.02 to $0.12 per common share in the third quarter of 2026 San Diego, Calif.,

$LYCAMedAI 8/10

Venrock Healthcare Capital Partners III, L.P. (Koh Bong Y, Shah Nimish P) purchased $37.7M of LYCA (indirect holdings)

Venrock Healthcare Capital Partners III, L.P. purchased 2,045,440 indirectly-held shares of Lycia Therapeutics, Inc. (LYCA) at an average of $18.41 ($18.00–$26.97, $37.65M total) across 6 trades over 2026-10-23 to 2026-10-27. Filed jointly with VHCP Co-Investment Holdings III, LLC (10% owner), VHCP Management III, LLC (10% owner), Venrock Healthcare Capital Partners EG, L.P. (10% owner), VHCP Management EG, LLC (10% owner), Venrock Healthcare Capital Partners XP, L.P. (10% owner), VHCP Management XP, LLC (10% owner), Koh Bong Y (10% owner) and Shah Nimish P (10% owner).